Rocuronium Bromide Injection, Solution
Product Images NDC 82449-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 82449-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Steriscience Specialties Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image-carton-1 (Carton Image)

Image-carton-1 (Carton Image)
Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) intravenous solution packaging label. The label includes the proprietary name Rocuronium Bromide Injection, strength 50 mg/5 mL, dosage form injection solution, and route intravenous. It states for intravenous use only and is labeled Rx Only. The labeler is STERISCIENCE SPECIALTIES PRIVATE LIMITED. The package contains 10 vials of 5 mL multiple-dose vials. Warnings about respiratory arrest and the need for artificial respiration are included on the label.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A box-and-whisker plot displaying data on minutes versus mg/kg doses of Rocuronium Bromide across three age groups: 18–64 years, 65 years and older, and 1–12 years. The x-axis shows dose categories in mg/kg, and the y-axis represents time in minutes.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A box plot chart depicting duration times in minutes for Rocuronium Bromide by age groups and dosages in mg/kg. The x-axis shows different age groups (18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years) with varying dosages. The y-axis shows the duration in minutes, illustrating variability and range across groups.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph depicting time in minutes on the vertical axis against an unspecified variable on the horizontal axis. It compares two doses of Rocuronium Bromide injection, solution: 0.15 mg/kg and 0.1 mg/kg, with sample sizes of 13 and 29 respectively. The graph shows increasing trends for both doses over the range shown.*
FDA Label Image

Structure Rocuronium (Structure Rocuronium)

Structure Rocuronium (Structure Rocuronium)
Chemical structure of rocuronium bromide, a steroidal neuromuscular blocking agent. The structure shows multiple cyclic rings, an ester group (CH3 COO), a quaternary ammonium group (N+), and a bromide ion (Br-).*
FDA Label Image

Vial-label-roc-br (Vial Image)

Vial-label-roc-br (Vial Image)
Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) solution for intravenous use in a 5 mL multiple-dose vial. The label includes a warning about paralysing effects and respiratory arrest risk. It states the product is sterile and nonpyrogenic, with storage instructions and manufacturer details from Steriscience Specialties Private Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.